PremiumCompany AnnouncementsInvex Therapeutics Unveils Promising Alzheimer’s Treatment Results Invex Therapeutics Announces AGM Results and Future Focus Invex Therapeutics Restructures Amid Clinical Trial Challenges PremiumCompany AnnouncementsInvex Therapeutics Embraces Corporate Governance Standards Invex Therapeutics Cuts Losses, Skips Dividend Invex Therapeutics Shareholder Voting Power Shifts PremiumCompany AnnouncementsInvex Therapeutics Advances Exenatide Development Invex Therapeutics Director Adjusts Holdings Invex Therapeutics Options Expire Unexercised